Fibrinolysis Shutdown and Thrombosis in a COVID-19 ICU
- PMID: 33989265
- DOI: 10.1097/SHK.0000000000001666
Fibrinolysis Shutdown and Thrombosis in a COVID-19 ICU
Conflict of interest statement
The author reports no conflicts of interest.
Comment on
-
Fibrinolysis Shutdown in Trauma: Historical Review and Clinical Implications.Anesth Analg. 2019 Sep;129(3):762-773. doi: 10.1213/ANE.0000000000004234. Anesth Analg. 2019. PMID: 31425218 Free PMC article. Review.
References
-
- Lackner H, Merskey C. Variation in fibrinolytic activity after acute myocardial and after the administration of oral anticoagulant drugs and intravenous heparin. Brit J Haemat 6:402–413, 1960.
-
- Chakrabarti R, Hocking ED, Fearnley GR. Reaction pattern to three stresses—electroplexy, surgery, and myocardial infarction—of fibrinolysis and plasma fibrinogen. J Clin Pathol 22 (6):659–662, 1969.
-
- Moore HB, Moore EE, Neal MD, Sheppard FR, Kornblith LZ, Draxler DF, Walsh M, Medcalf RL, Cohen MJ, Cotton BA, et al. Fibrinolysis shutdown in trauma: historical review and clinical implications. Anesth Analg 129 (3):762–773, 2019.
-
- Kelly J, Rudd A, Lewis RR, Hunt BJ. Plasma D-dimers in the diagnosis of venous thromboembolism. Arch Intern Med 162 (7):747–756, 2002.
-
- Ibanez C, Perdomo J, Calvo A, Ferrando C, Reverter JC, Tassies D, Blasi A. High D dimers and low global fibrinolysis coexist in COVID19 patients: what is going on in there? J Thromb Thrombolysis 2020; 1–5.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
